TXG CapEx to Revenue

10X Genomics Inc Class A · CapEx to Revenue

TXG logo

TXG CapEx to Revenue

Current (TTM)0.92%
TXG CapEx/Revenue (5.28% → 0.92%)
High-resolution chart · PNG

TXG capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

10X Genomics Inc Class A CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
0.9233%
2.029%
8.0042%
25.4955%
20.6483%
12.8475%
17.3925%
4.5854%
5.2838%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.